The PANORAMIC trial will assess antiviral medications in early stages of infection.
The hope is that these treatments will reduce the severity of the disease and become an important treatment alongside vaccinations and other measures.
You can join the trial if:
- You are aged 50 or over
- You are aged between 18-49 with an underlying condition which makes you clinically more vulnerable
- You have had a positive covid-19 test and you are within five days of the onset of symptoms.
If you join the trial you will be randomised to either receive standard care (no additional treatment) or the antiviral drug Molnupiravir
We will be proactively contacting people who fit the criteria to see if you would be interested in taking part, you can also contact us to enrol via email at firstname.lastname@example.org. Alternatively you can sign up yourself at the study website.